The requirement of p47 phosphorylation for activation of NADPH oxidase by opsonized zymosan in human neutrophils

This publication has 50 references indexed in Scilit:

• The activity of a beta subtype of protein kinase C purified from nuclei of human neutrophils is enhanced by treatment with phorbol 12-myristate 13-acetate
  Biochemical and Biophysical Research Communications, 1991
• A novel conformationally restricted protein kinase C inhibitor, Ro 31‐8425, inhibits human neutrophil superoxide generation by soluble, particulate and post‐receptor stimuli
  FEBS Letters, 1991
• NADPH-oxidase activation by protein kinase C-isotypes
  Biochemical and Biophysical Research Communications, 1991
• Genetic Variants of Chronic Granulomatous Disease: Prevalence of Deficiencies of Two Cytosolic Components of the NADPH Oxidase System
  New England Journal of Medicine, 1989
• A phosphoprotein of Mr 47,000, defective in autosomal chronic granulomatous disease, copurifies with one of two soluble components required for NADPH:O2 oxidoreductase activity in human neutrophils.
  Journal of Clinical Investigation, 1989
• The mechanism of protein kinase C activation
  Trends in Neurosciences, 1989
• Stimulated neutrophils from patients with autosomal recessive chronic granulomatous disease fail to phosphorylate a Mr-44,000 protein
  Nature, 1985
• Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide-dependent protein kinase and protein kinase C
  Biochemistry, 1984
• The respiratory burst of phagocytes.
  Journal of Clinical Investigation, 1984
• Catalytic properties of the resolved flavoprotein and cytochrome B components of the NADPH dependent O2−• generating oxidase from human neutrophils
  Biochemical and Biophysical Research Communications, 1984